These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 3682435)
1. The usefulness of CEA as an indicator for early detection and a guide to the treatment of recurrent gastric cancer. Kano T; Koga T; Souda K; Abe Y; Yonemura T; Oka N; Inokuchi K Jpn J Surg; 1987 Jul; 17(4):269-75. PubMed ID: 3682435 [TBL] [Abstract][Full Text] [Related]
2. Serial determinations of carcinoembryonic antigen for early detection of recurrent gastric cancer. Tamada R; Hiramoto Y; Abe Y; Nouzuka T; Okamura T; Masuda H; Kano T; Kumashiro R; Inokuchi K Jpn J Surg; 1982; 12(6):429-33. PubMed ID: 7166914 [TBL] [Abstract][Full Text] [Related]
3. Use of CEA as an indicator of early recurrence and as a guide to a selected second-look procedure in patients with colorectal cancer. Wanebo JH; Stearns M; Schwartz MK Ann Surg; 1978 Oct; 188(4):481-93. PubMed ID: 697433 [TBL] [Abstract][Full Text] [Related]
4. Carcinoembryonic antigen in gastric cancer patients. Shimizu N; Wakatsuki T; Murakami A; Yoshioka H; Hamazoe R; Kanayama H; Maeta M; Koga S Oncology; 1987; 44(4):240-4. PubMed ID: 3614814 [TBL] [Abstract][Full Text] [Related]
5. The clinical usefulness of preoperative CEA determination in gastric cancer. Koga T; Kano T; Souda K; Oka N; Inokuchi K Jpn J Surg; 1987 Sep; 17(5):342-7. PubMed ID: 3430898 [TBL] [Abstract][Full Text] [Related]
6. The usefulness of CEA and/or CA19-9 in monitoring for recurrence in gastric cancer patients: a prospective clinical study. Takahashi Y; Takeuchi T; Sakamoto J; Touge T; Mai M; Ohkura H; Kodaira S; Okajima K; Nakazato H; Gastric Cancer; 2003; 6(3):142-5. PubMed ID: 14520526 [TBL] [Abstract][Full Text] [Related]
7. Carcinoembryonic antigen levels in the peritoneal cavity: useful guide to peritoneal recurrence and prognosis for gastric cancer. Nishiyama M; Takashima I; Tanaka T; Yoshida K; Toge T; Nagata N; Iwamori S; Tamura Y World J Surg; 1995; 19(1):133-7; discussion 137. PubMed ID: 7740800 [TBL] [Abstract][Full Text] [Related]
8. Serum CEA levels facilitate detection of recurrences of cancer in patients after gastrectomy. Tamada R; Hiramoto Y; Tsujitani S; Nozuka T; Okamura T; Masuda H; Sugimachi K; Inokuchi K Jpn J Surg; 1985 Jan; 15(1):23-9. PubMed ID: 2985853 [TBL] [Abstract][Full Text] [Related]
9. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer. Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401 [TBL] [Abstract][Full Text] [Related]
10. Carcinoembryonic antigen measurements in the management of esophageal cancer: an indicator of subclinical recurrence. Clark GW; Ireland AP; Hagen JA; Collard JM; Peters JH; DeMeester TR Am J Surg; 1995 Dec; 170(6):597-600; discussion 600-1. PubMed ID: 7492008 [TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of CEA expression by RT-PCR in peritoneal wash from patients with gastric cancer: result of a 5-year follow-up after curative resection. Chae HD; Kim IH Scand J Gastroenterol; 2016 Aug; 51(8):956-60. PubMed ID: 27162096 [TBL] [Abstract][Full Text] [Related]
12. Tumor markers for diagnosis, monitoring of recurrence and prognosis in patients with upper gastrointestinal tract cancer. Jing JX; Wang Y; Xu XQ; Sun T; Tian BG; Du LL; Zhao XW; Han CZ Asian Pac J Cancer Prev; 2014; 15(23):10267-72. PubMed ID: 25556459 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of early postoperative tumor marker response in gastric cancer. Nam DH; Lee YK; Park JC; Lee H; Shin SK; Lee SK; Lee YC; Cheong JH; Hyung WJ; Noh SH; Kim CB Ann Surg Oncol; 2013 Nov; 20(12):3905-11. PubMed ID: 23807661 [TBL] [Abstract][Full Text] [Related]
14. Indicative value of carcinoembryonic antigen (CEA) for liver recurrence following curative resection of stage II and III gastric cancer. Ikeda Y; Mori M; Kajiyama K; Kamakura T; Maehara Y; Haraguchi Y; Sugimachi K Hepatogastroenterology; 1996; 43(11):1281-7. PubMed ID: 8908563 [TBL] [Abstract][Full Text] [Related]
15. Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy. Sun Z; Zhang N World J Surg Oncol; 2014 Dec; 12():397. PubMed ID: 25543664 [TBL] [Abstract][Full Text] [Related]
16. Radioimmunoguided surgery in recurrent colorectal cancer: the role of carcinoembryonic antigen, computerized tomography, and physical examination. Sardi A; Agnone CM; Nieroda CA; Mojzisik C; Hinkle G; Ferrara P; Farrar WB; Bolton J; Thurston MO; Martin EW South Med J; 1989 Oct; 82(10):1235-44. PubMed ID: 2799440 [TBL] [Abstract][Full Text] [Related]
17. Peritoneal carcinoembryonic antigen level for predicting locoregional and distant spread of gastric cancer. Cetin B; Atalay C; Aslan S; Babacan B; Hatipoğlu C; Akinci M; Cetin A Surg Today; 2005; 35(11):919-24. PubMed ID: 16249844 [TBL] [Abstract][Full Text] [Related]
18. Peritoneal lavage CEA/CA125 is a prognostic factor for gastric cancer patients. Yamamoto M; Baba H; Toh Y; Okamura T; Maehara Y J Cancer Res Clin Oncol; 2007 Jul; 133(7):471-6. PubMed ID: 17226046 [TBL] [Abstract][Full Text] [Related]